BMS 181174

• Description:

  BMS 181174 is a Mitomycin C (HY-13316) analogue. BMS 181174 exhibits anticancer activity and can be used for the research of cancer, such as colorectal cancer[1].

• UNSPSC:

  12352005

• Target:

  Drug Derivative

• Related Pathways:

  Others

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Smiles:

  CO[C@]12N(C[C@@]3([H])[C@]2([H])N3)C4=C(C(C(NCCSSC5=CC=C(C=C5)[N+]([O-])=O)=C(C4=O)C)=O)[C@H]1COC(N)=O

• Molecular Formula:

  C23H25N5O7S2

• Molecular Weight:

  547.60

• References & Citations:

  [1]Macaulay VM, et al. Phase I study of the mitomycin C analogue BMS-181174. Br J Cancer. 1998 Jun;77 (11) :2020-7.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [95056-36-3]